Quarry LP’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,343
Closed -$108K 2437
2026
Q1
$108K Buy
+1,343
New +$111K 0.02% 478
2025
Q4
Sell
-461
Closed -$35.9K 2285
2025
Q3
$35.9K Sell
461
-4,941
-91% -$386K 0.01% 1047
2025
Q2
$422K Buy
5,402
+4,583
+560% +$342K 0.09% 196
2025
Q1
$59.4K Sell
819
-6,178
-88% -$442K 0.01% 725
2024
Q4
$518K Buy
6,997
+3,786
+118% +$265K 0.07% 142
2024
Q3
$212K Buy
+3,211
New +$233K 0.05% 222
2024
Q2
Sell
-448
Closed -$42.8K 1885
2024
Q1
$42.8K Sell
448
-235
-34% -$19.7K 0.01% 539
2023
Q4
$52.1K Sell
683
-649
-49% -$45.2K 0.01% 318
2023
Q3
$92.3K Buy
1,332
+836
+169% +$67.2K 0.02% 210
2023
Q2
$46.8K Sell
496
-300
-38% -$26.1K 0.02% 256
2023
Q1
$65.9K Buy
796
+470
+144% +$36.9K 0.01% 197
2022
Q4
$24.3K Buy
+326
New +$25.1K 0.01% 287

Other funds holding EW

Quarry LP's EW Position: Q2 2026 in Review

Quarry LP sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 1,343 shares — an estimated $108K sold.

Quarry LP first reported a position in EW in Q4 2022 and held it in 12 quarters. The position peaked at $518K in Q4 2024. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Quarry LP reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
  • Quarry LP sold 1,343 Edwards Lifesciences shares in Q2 2026, an estimated $108K.
  • Quarry LP first reported a position in Edwards Lifesciences in Q4 2022 and held it in 12 quarters.
  • Quarry LP's Edwards Lifesciences position peaked at $518K in Q4 2024.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.